RecallDepth
Class III Terminated

Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intravenous Use, Not for Use in Newborns, Contains Benzyl Alcohol, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ, 08520, Made in India, NDC 55150-295-20.

Company
Auromedics Pharma Llc
Recall Initiated
February 7, 2020
Posted
February 26, 2020
Recall Number
D-0853-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4600 Vials
Firm Location
East Windsor, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).

Distribution

Ohio, Louisiana, Mississippi

Lot / Code Info

Lot #CGP190001-A, Exp. 07/31/2020

More recalls by Auromedics Pharma Llc

View all recalls by this company →

Other recent Class III Drug recalls